Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Alba (Baltimore, Md.) granted Shire (LSE:SHP; SHPGY) exclusive rights to commercialize AT-1001 outside the
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury